COMMUNITY HEALTH SYSTEMS INC (CYH)
Health Care · hospital systems · NYSE
Community Health Systems is a national operator of acute care hospitals and outpatient centers focused on delivering healthcare services in local communities.
What COMMUNITY HEALTH SYSTEMS INC does
Community Health Systems, Inc. is a leading operator of general acute care hospitals and outpatient facilities in communities across the United States. The company provides a broad range of healthcare services, including general acute care, emergency services, surgical procedures, and diagnostic testing through its network of affiliated hospitals and clinics.
Themes: hospital management, outpatient care services, healthcare operations
Fundamentals
- Price$2.85 as of 2026-10-20 close
- Market cap$402M as of 2026-07-16 (share count; price 2026-10-20)
- 1-year return-10.7% 2025-10-20 close $3.19 → 2026-10-20 close $2.85
- P/E1.54 as of 2026-10-20
- Net margin+4.1% FY2025, SEC XBRL
- ROICn/a No figure: its stockholders' equity is zero or negative.
- Debt / equityn/a No figure: its stockholders' equity is zero or negative, where the ratio means nothing.
- Revenue growth (YoY)-1.2% FY2025, SEC XBRL
- Revenue CAGR (3y)+0.7% SEC XBRL
- Beta1.15 as of 2026-09-03
- Last reported earnings2026-07-22 SEC EDGAR Form 8-K (Item 2.02)
Dividend: at least 1 years of non-decreasing per-share dividends (SEC XBRL) — we do not hold the year before it, so the real streak may be longer.
How CYH compares in its sector
- price-to-earnings ratiobottom 10% 181 covered Health Care peers, as of 2026-10-20
- net profit marginmiddle range 430 covered Health Care peers, as of 2026-09-03
- operating margintop 25% 417 covered Health Care peers, as of 2026-09-03
- 3-year revenue CAGRmiddle range 402 covered Health Care peers
- free cash flow (absolute dollars, latest fiscal year)top 25% 494 covered Health Care peers, as of FY2025
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Dividend coverage
Not assessed — last reported dividend predates the accounts. The most recent fiscal year in which CYH reported a dividend payment is FY2012, while its reported financial statements run through FY2025. Coverage is therefore not assessed for the latest year — an FY2012 ratio would not describe CYH today.
Coverage is derived from reported SEC EDGAR XBRL figures, comparing dividends paid against net income and free cash flow for the SAME fiscal year. It is not shown here because the latest fiscal year with a reported dividend payment (FY2012) is older than the latest year of reported financial statements (FY2025), so any ratio would describe an out-of-date year. Informational only — not financial advice.
Quarterly results
| Quarter | Revenue | Operating income | Net income | Diluted EPS | Operating cash flow | Capex |
|---|---|---|---|---|---|---|
| Q2 FY2026 2026-06-30 | $2.8B | $389M | $70M | $0.51 | $88M† | $76M† |
| Q1 FY2026 2026-03-31 | $3.0B | $281M | -$58M | -$0.43 | -$297M | $76M |
| Q4 FY2025 2025-12-31 | $3.1B† | $450M† | $110M† | $0.80† | $266M† | $94M† |
| Q3 FY2025 2025-09-30 | $3.1B | $243M | $130M | $0.96 | $69M† | $65M† |
| Q2 FY2025 2025-06-30 | $3.1B | $512M | $282M | $2.09 | $88M† | $91M† |
| Q1 FY2025 2025-03-31 | $3.2B | $284M | -$13M | -$0.10 | $120M | $85M |
| Q4 FY2024 2024-12-31 | $3.3B† | $278M† | -$70M† | -$0.52† | $216M† | $109M† |
| Q3 FY2024 2024-09-30 | $3.1B | -$205M | -$391M | -$2.95 | $67M† | $70M† |
† Not filed as a discrete quarter: derived from the company's own year-to-date figures (for example the fourth quarter as the fiscal year minus the first nine months). A derived per-share figure is approximate, because the share count moves within the year.
Balance sheet at 2026-06-30
- Cash and equivalents$149M
- Total debt$9.6B borrowings only; leases excluded
- Net debt$9.4B total debt − cash − short-term investments
From the company's own SEC 10-Q and 10-K filings (XBRL), re-read every week. Figures in US dollars as filed; informational only — not financial advice.
How COMMUNITY HEALTH SYSTEMS INC looks technically
COMMUNITY HEALTH SYSTEMS INC (CYH) is trading 6.8% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average crossed below its 200-day average about 121 trading days ago — a "death cross", a bearish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 15, below the 25 that marks a real trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 48, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bullish about 6 trading days ago (its momentum flipped positive). It made a new 20-day low about 13 trading days ago. It is 35.7% below its highest point of the past year.
Trend
7
| Distance from the 200-day | it is trading 6.8% below its 200-day average, the long-term trend line — a long-term downtrend | -6.8% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $2.90 | $2.90 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $3.06 | $3.06 |
| Swing structure | its recent peaks and dips disagree — one of them is rising while the other is not, so there is no clean up or down pattern in the swings | mixed — one of the two is not confirming |
| Last swing turn | its last significant turn was a swing high 27 calendar days ago — the swings before that are what the structure reading is measured on | 27 sessions |
| Since the 50/200 cross | its 50-day average crossed below its 200-day average about 121 trading days ago — a "death cross", a bearish long-term signal | 121 sessions |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 15, below the 25 that marks a real trend) | 14.9 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 48, neither overbought (above 70) nor oversold (below 30) | 48.5 |
|---|---|---|
| Position in its 14-day range | it is trading in the lower half of its 14-day range ($2.69 to $3.05) — its "stochastic" reading is 44 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 44.4 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bullish about 6 trading days ago (its momentum flipped positive) | 6 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $4.43 | $4.43 |
|---|---|---|
| From the 52-week high | it is 35.7% below its 52-week high (its highest price of the past year) | -35.7% |
| Above the 52-week low | it is 18.5% above its 52-week low (its lowest price of the past year) | +18.5% |
| Below the 52-week high | it is 35.7% below its highest point of the past year | 35.7% |
| Since a 20-day breakout | it made a new 20-day low about 13 trading days ago | 13 sessions |
| Since a 55-day breakout | it made a new 55-day low about 59 trading days ago | 59 sessions |
| All-time high | its highest closing price on record is $53.72 (set on 2015-06-29) | $53.72 |
| Given back of the 52-week move | over the past year its closes ranged ($2.49 to $4.41), and it has recovered roughly a quarter of its fall from last year’s high — 19% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $3.68 to $3.74. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 18.8% |
| From the all-time high | it is 94.7% below its all-time high | -94.7% |
| Nearest price level | it is trading 1.1% above a support level at $2.82 — a price it turned at six times since 2025-01-14, most recently on 2026-09-09. Since 2024-10-21 it has 4 such levels below the current price and 11 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -1.1% |
| All-time low | its lowest closing price on record is $1.79 (set on 2019-08-27) | $1.79 |
| Above the all-time low | it is 59.2% above its all-time low | +59.2% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are about average versus its own recent 6-month history | 44th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.119 between its high and its low — about 4.2% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.119 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $2.65 and $3.05 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $2.65 – $2.85 – $3.05 |
| Typical daily range (% of price) | its price moves about 4.2% in a typical session — about typical for the companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 4.2% |
| Stretch from the 200-day average | it is trading 1.7 daily ranges below its 200-day average price (6.8% below it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 1.7 daily ranges below its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.91× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
1
| Since a doji | 3 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 3 sessions ago |
|---|
Price gaps
1
| Gap at the open | it opened on 2026-10-20 1.5% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and had not traded back through that level by the close | +1.4% |
|---|
Price streaks
1
| Closing streak | it closed higher in its latest session, after a session that did not close higher — a single up day rather than a run | 1 session up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 1.7 percentage points (the stock lost 0.7% while the market gained 1.0%) | -1.7% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 12.3 percentage points (the stock lost 8.7% while the market gained 3.6%) | -12.3% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 18.0 percentage points (the stock lost 9.5% while the market gained 8.5%) | -18.0% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 25.2 percentage points (the stock lost 10.7% while the market gained 14.6%) | -25.2% |
Signal agreement
2
| Bullish technical signals | 1 of the 9 technical signals we can compute for it is currently in a bullish state: MACD momentum is positive — these describe past price behaviour, not a forecast | 1 of 9 |
|---|---|---|
| Bearish technical signals | 4 of the 9 technical signals we can compute for it are currently in a bearish state: a "death cross" — its 50-day average is below its 200-day, trading below its 200-day average, lagging the market over 6 months, trading below the Ichimoku cloud — these describe past price behaviour, not a forecast | 4 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 1.7% below the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-14 and projected forward over today's price, the side traders read as an established downtrend, with the band above acting as the level that would have to be cleared. The band itself is thick, spanning 13.3% of the share price, which is taken to mean a barrier that has held for a while and takes effort to cross. | -1.7% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 7% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $3.05 — a volume-weighted average of daily closes over 198 sessions, not a true tick-by-tick VWAP. | -6.6% |
|---|---|---|
| Vs the average paid since it last reported | the price is 1% below the average price paid since it last reported on 2026-07-22 (its 8-K), so the typical buyer over that stretch is under water. That average is $2.87 — a volume-weighted average of daily closes over 64 sessions, not a true tick-by-tick VWAP. | -0.8% |
Price levels it has turned at before
CYH last closed at $2.85 on 2026-10-20. Since 2024-10-21 it has turned at 4 prices below its last close and 11 above; the 3 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $2.82 | Support | 1.1% below the last close | turned there six times · 2025-01-14 to 2026-09-09 |
| $2.92 | Resistance | 2.5% above the last close | turned there four times · 2024-12-30 to 2026-05-27 |
| $2.99 | Resistance | 4.9% above the last close | turned there five times · 2025-06-16 to 2026-06-23 |
| $2.70 | Support | 5.2% below the last close | turned there three times · 2026-05-11 to 2026-06-01 |
| $3.06 | Resistance | 7.2% above the last close | turned there six times · 2025-02-03 to 2026-09-23 |
| $2.39 | Support | 16.1% below the last close | turned there twice · 2025-08-04 to 2026-04-24 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
No Elliott-wave labelling currently fits its swings: the recent highs and lows do not satisfy the three rules a five-wave count has to obey, so there is no count to show rather than a count we are unsure about.
Read from daily closes as of 2026-10-20.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading below the 200-day moving average · Trading below the 50-day moving average · Pulled back from the 12-month high · trendless / choppy (low ADX) · lagging the market · Trading below the Ichimoku cloud | Learn: moving average · golden cross · adx · rsi · macd · breakout · fifty two week high low
Based on daily closing prices as of 2026-10-20. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingHold (3.10 mean, 1=Strong Buy…5=Strong Sell) — 8 analysts
- Mean price target$3.09 range $2.00 – $4.00; median $3.00
Analyst estimates, as of 2026-10-15. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for CYH
- Consensus EPS estimate-$0.3243 next reporting period, as of 2026-10-15
- Estimate change, 30 days$0.00 from -$0.3243, on 2026-09-10, 35-day window
- Readings revised upward0% of 10 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Significant levels of long-term debt and interest payment obligations.","Operating losses and volatility in net income impacted by facility divestitures and impairment charges.","Regulatory and reimbursement risks, including shifts in government and private payer healthcare policies."]
What changed in the latest 10-Q
AI-assisted comparison of CYH's 10-Q filed 2026-07-23 against the prior one filed 2026-04-22.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing (2026-07-23) states the company operates in 32 distinct markets across 12 states, as of June 30, 2026.
- Newer filing (2026-07-23) states subsidiaries own or lease 60 affiliated hospitals with more than 8,000 beds, as of June 30, 2026.
- Newer filing (2026-07-23) states the company operates more than 800 sites of care, as of June 30, 2026.
- Newer filing (2026-07-23) reports six months ended June 30, 2026 acquisition activity of approximately $53 million for certain physician practices, clinics, and controlling interests in two ambulatory surgery centers.
- Newer filing (2026-07-23) reports six months ended June 30, 2026 divestiture of four hospitals in Arkansas, three hospitals in Pennsylvania, one hospital in Alabama, and the sale of an 80% ownership interest in one hospital in Tennessee, with 2025 annual net operating revenues of approximately $1.6 billion and total net proceeds of approximately $1.2 billion.
- Newer filing (2026-07-23) divestiture table includes 2026 divestitures: Crestwood Medical Center (Huntsville Hospital Health System, Huntsville, Alabama, 180 beds, April 1, 2026), Northwest Medical Center - Bentonville (Freeman Health System, Bentonville, Arkansas, 128 beds, June 1, 2026), Northwest Medical Center - Springdale (Freeman Health System, Springdale, Arkansas, 222 beds, June 1, 2026), Willow Creek Women's Hospital (Freeman Health System, Johnson, Arkansas, 64 beds, June 1, 2026), Siloam Springs Regional Hospital (Freeman Health System, Siloam Springs, Arkansas, 73 beds, June 1, 2026).
- Newer filing (2026-07-23) overview section covers results for the three months ended June 30, 2026 and six months ended June 30, 2026.
- Newer filing (2026-07-23) reports net operating revenues decreased from $3.133 billion for the three months ended June 30, 2025 to $2.825 billion for the three months ended June 30, 2026.
- Newer filing (2026-07-23) reports same-store net operating revenues for the three months ended June 30, 2026 increased $65 million compared to the same period in 2025.
- Newer filing (2026-07-23) reports net income of $104 million during the three months ended June 30, 2026, compared to $320 million for the same period in 2025.
- Newer filing (2026-07-23) reports net income for the three months ended June 30, 2026 included an after-tax charge of $4 million for loss from early extinguishment of debt, an after-tax charge of $2 million for employee terminations and other restructuring charges, and an after-tax benefit of $101 million primarily from a gain from the divestiture of one hospital, partially offset by a net impairment charge for a hospital sold below carrying value and an impairment charge for idled, disposed or held-for-sale assets.
- Newer filing (2026-07-23) reports net income for the three months ended June 30, 2025 included an after-tax benefit of $139 million for gain from early extinguishment of debt and an after-tax benefit of $151 million from a gain related to the divestiture of two hospitals, partially offset by a loss on the divestiture of an ownership interest in a hospital and impairment of certain long-lived assets.
- Newer filing (2026-07-23) reports consolidated inpatient admissions for the three months ended June 30, 2026 decreased 11.4% compared to the same period in 2025, consolidated adjusted admissions decreased 11.7%, same-store inpatient admissions increased 1.9%, and same-store adjusted admissions increased 2.9%.
- Newer filing (2026-07-23) reports net operating revenues decreased from $6.292 billion for the six months ended June 30, 2025 to $5.790 billion for the six months ended June 30, 2026.
- Newer filing (2026-07-23) reports same-store net operating revenues for the six months ended June 30, 2026 increased $135 million compared to the same period in 2025.
- Removed:
- Older filing (2026-04-22) states the company operates in 34 distinct markets across 13 states, as of March 31, 2026.
- Older filing (2026-04-22) states subsidiaries own or lease 65 affiliated hospitals with more than 9,000 beds, as of March 31, 2026.
- Older filing (2026-04-22) states the company operates more than 900 sites of care, as of March 31, 2026.
- Older filing (2026-04-22) reports three months ended March 31, 2026 acquisition activity of approximately $5 million for certain physician practices, clinics, and a controlling interest in an ambulatory surgery center.
- Older filing (2026-04-22) reports three months ended March 31, 2026 divestiture of three hospitals in Pennsylvania and the sale of an 80% ownership in one hospital in Tennessee, with 2025 annual net operating revenues of approximately $827 million and total net proceeds of approximately $657 million.
- Older filing (2026-04-22) divestiture table covers only the three months ended March 31, 2026 and includes 2026 divestitures: Tennova Healthcare - Clarksville, Wilkes-Barre General Hospital, Regional Hospital of Scranton, and Moses Taylor Hospital.
- Older filing (2026-04-22) separately discloses the completed disposition effective April 1, 2026 of Crestwood Medical Center in Huntsville, Alabama (180 beds) to The Health Care Authority of the City of Huntsville, with proceeds of approximately $459 million, and the March 5, 2026 definitive agreement with Freeman Health System for four Arkansas hospitals for $112 million.
- Older filing (2026-04-22) overview section covers results for the three months ended March 31, 2026.
- Older filing (2026-04-22) reports net operating revenues decreased from $3.159 billion for the three months ended March 31, 2025 to $2.965 billion for the three months ended March 31, 2026.
- Older filing (2026-04-22) reports same-store net operating revenues for the three months ended March 31, 2026 increased $88 million compared to the same period in 2025.
- Older filing (2026-04-22) reports net loss of $25 million during the three months ended March 31, 2026, compared to net income of $25 million for the same period in 2025.
- Older filing (2026-04-22) reports net loss for the three months ended March 31, 2026 included an after-tax charge of $8 million for loss from early extinguishment of debt and an after-tax benefit of $15 million primarily from a gain from the divestiture of the company's controlling interest in a hospital.
- Reworded:
- The older filing (2026-04-22) divestiture section describes the Crestwood Medical Center and Arkansas hospital dispositions as separate pending/completed transactions with detailed terms; the newer filing (2026-07-23) instead includes these dispositions in the completed divestiture table without the separate narrative details.
- Notes:
- The newer filing text appears truncated at the end of the overview section, so later portions cannot be compared.
- The older filing text appears truncated mid-sentence in the overview section, so a complete comparison of that section is not possible.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
0 open-market purchases and 1 open-market sale by insiders in the last 90 days, of which we have read Form 4 filings through 2026-10-16. The 5 days since 2026-10-16 have not been checked yet.
- Last 90 days · read to 2026-10-160 buys · 1 sell ($118400) — 1 selling insider
- Last 180 days · read to 2026-10-160 buys · 1 sell ($118400) — 1 selling insider
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-08-25. Based on Form 4 filings read through 2026-10-16; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about CYH's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
4 institutional 13F filers reported holding CYH as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 4
- Reported shares held 16,318,551
- Reported value $54,503,958
reported quarterly holdings change (2026-03-31 → 2026-06-30): 0 new, 3 increased, 1 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about CYH's institutional holders → See what each manager we track holds →
Short interest (FINRA)
CYH had 12,357,187 shares of reported short interest as of the 2026-09-30 FINRA settlement date (delayed, bi-monthly; not real-time).
CYH had 8.76% of its shares outstanding sold short as of the 2026-09-30 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 9.77 days to cover at the same settlement.
- Reported short interest (shares) 12,357,187
- Short interest (% of shares outstanding) 8.76%
- Prior settlement (shares) 13,549,537
- Reported change -8.8%
- Days to cover (reported) 9.77
Reported to FINRA as of the 2026-09-30 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- HCA Healthcare (HCA)
- Tenet Healthcare (THC)
- Universal Health Services (UHS)
- Lifepoint Health
- Ardent Health Services
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare CYH vs…
CYH ranks in…
Frequently asked questions
What does COMMUNITY HEALTH SYSTEMS INC (CYH) do?
Community Health Systems, Inc. is a leading operator of general acute care hospitals and outpatient facilities in communities across the United States. The company provides a broad range of healthcare services, including general acute care, emergency services, surgical procedures, and diagnostic testing through its network of affiliated hospitals and clinics.
What sector is COMMUNITY HEALTH SYSTEMS INC (CYH) in?
COMMUNITY HEALTH SYSTEMS INC (CYH) is classified in the Health Care sector. Its industry is hospital systems. It trades on NYSE.
Who are COMMUNITY HEALTH SYSTEMS INC's (CYH) competitors?
Notable peers of COMMUNITY HEALTH SYSTEMS INC (CYH) include HCA Healthcare, Tenet Healthcare, Universal Health Services, Lifepoint Health and Ardent Health Services. This peer set is informational only — not financial advice.
Is COMMUNITY HEALTH SYSTEMS INC (CYH) overbought or oversold right now?
COMMUNITY HEALTH SYSTEMS INC (CYH) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 48, in the neutral middle (as of 2026-10-20). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on CYH come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest; prices are market data, as of 2026-09-03; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-20.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.